as was aptly described by Carl B. Feldbaum, president of the BioTech Industry Organization, ``Life-saving new drugs do take too long to reach the people who need them.'' From my district in Montgomery County, PA, I have heard many a compelling story from constituents with cancer, Lou Gehrig's Disease, epilepsy, or AIDS who speak of the difficulties in accessing the medicines they need because the approval process in our country is so prolonged and, in effect, they have to turn to other countries where the products are available. Don't get me wrong. The Food and Drug Administration serves a valuable purpose in maintaining high safety and efficacy standards. However, it is important to note that the FDA's actions directly affect the lives of patients and the ability of physicians to provide state-of-the-art care for their patients. In addition, the FDA regulates businesses that produce 25 percent of America's gross national product, so the Agency's actions also impact our country's economic well-being. The pharmaceutical industry is an excellent example. The United States leads the world in discovering new drugs yet, all too often, these drugs are available overseas first. The United States is far and away the world leader in biotechnology, but many biotechnology firms are moving clinical trials overseas because of red tape imposed on them by the FDA.
Editor's note · Context
Discussing the challenges of drug approval processes and their impact on patients and the economy.
Share
More from Jon Fox
one of the related bills that I have, and I hope that would also see legislative action, and that would be what I call the sunset review of Federal agencies. It is something we did in Pennsylvania where we evaluated all of the State…
I think, you know, you deserve a great deal of credit for being a visionary on this. You know, while some people look at one bill at a time, you are looking at it from a 4- or 5-year projection. As you are looking for your children and…
Mr. Chairman, I include the following statement for the Record in support of the Regula-Skaggs-Fox amendment, and I thank the chairman for his leadership in this bill and in the House: Mr. Speaker, I wish to thank the gentleman from Ohio…
Many individuals have experienced enforcement powers of the IRS at their worst. Reports by GAO uncovered tales told by many taxpayers of unfair, unruly, and sometimes illegal treatment by IRS employees toward taxpayers demanding additional…





